Consolidated figures · ₹ crore
| ₹ Cr | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| 163 | 172 | 182 | 158 | |
| COGS | 61 | 60 | 64 | 57 |
| Gross profit | 102 | 112 | 118 | 102 |
| 46 | 52 | 56 | 47 | |
| 55 | 60 | 63 | 55 | |
| OPM % | 34.1% | 34.8% | 34.3% | 34.7% |
| Depreciation | 4 | 4 | 4 | 4 |
| Interest | 2 | 1 | 2 | 2 |
| 10 | 7 | 6 | 5 | |
| Profit before tax | 60 | 62 | 63 | 54 |
| Tax | 13 | 14 | 14 | 14 |
| Tax % | 21.4% | 22.8% | 22.6% | 25.3% |
| 47 | 48 | 49 | 41 | |
| PAT margin % | 28.8% | 27.7% | 26.6% | 25.7% |
| EPS (₹) | 4.2 | 4.3 | 4.4 | 3.6 |
| Results filing | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | — |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Pharmaceutical, food and nutrition | 108.41 | 40.02 | 786.91 | 245.82 | 541.09 |
| Speciality Ingredients | 49.86 | 10.89 | 463.07 | 51.99 | 411.08 |
| inter segment revenues | 2.09 | 0 | 0 | 0 |
₹ crore by quarter
| — |